News

Mindera Health™ announces publication of positive results from STAMP-1 and STAMP-2 studies

Observational studies leverage machine learning to create Mind.PxTM, a test that prospectively predicts biologic class response for individual psoriasis patients with high Positive Predictive Values (PPV) SAN DIEGO, CA – November 16, 2021 – Mindera Health™, developers of the ground-breaking Dermal Intelligence™ platform that is the first realization of personalized medicine in psoriasis,  has announced […]

Mindera Health™ announces publication of positive results from STAMP-1 and STAMP-2 studies Read More »

Sight Sciences Reports Third Quarter 2021 Financial Results

Sight Sciences Reports Third Quarter 2021 Financial Results   MENLO PARK, Calif., November 10, 2021 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform standards of care and improve patients’ lives, today reported financial results for the quarter ended September 30, 2021.   Recent Business

Sight Sciences Reports Third Quarter 2021 Financial Results Read More »

Sight Sciences Announces FDA Authorization for the PRECISION Trial, a Groundbreaking Three-Arm Randomized, Controlled IDE Trial

MENLO PARK, Calif.— November 10, 2021— Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform standards of care and improve patients’ lives, today announced that the Food and Drug Administration (FDA) has granted an Investigational Device Exemption (IDE) authorizing the Company to conduct a clinical study to

Sight Sciences Announces FDA Authorization for the PRECISION Trial, a Groundbreaking Three-Arm Randomized, Controlled IDE Trial Read More »

Potrero Medical Announces Launch of New Furosemide Stress Test App

HAYWARD, Calif., November 8, 2021 – Potrero Medical, innovator of the Accuryn Monitoring System, announced the launch of its newest software App for the Accuryn™ Monitor and AccuTab™. The Accuryn Monitoring System includes a revolutionary sensor-integrated foley catheter that provides real-time, actionable information to healthcare providers, enabling them to take important, earlier steps to prevent

Potrero Medical Announces Launch of New Furosemide Stress Test App Read More »

Procyrion’s Aortix Percutaneous Mechanical Circulatory Support Device to be Showcased at TCT 2021 Annual Meeting

Series of Presentations Highlights Company’s Novel Intra-aortic Pump that Treats Patients with Heart Failure and Worsening Renal Function HOUSTON, TX – NOVEMBER 2, 2021 – Procyrion, Inc., a medical device company dedicated to improving outcomes for patients with cardiac and renal impairment, announced today the schedule of presentations to be featured at the annual Transcatheter

Procyrion’s Aortix Percutaneous Mechanical Circulatory Support Device to be Showcased at TCT 2021 Annual Meeting Read More »

Empirical Spine Presents Data from Study of the LimiFlex™ — Empirical Spine

Presentation highlights return to work, ADL, and disability improvement in 246 subjects with 12-month follow-up. SAN CARLOS, Calif., November 2, 2021, / OrthoSpineNews / – Empirical Spine, Inc., a Silicon-Valley based medical technology company, announced today that data from the IDE study of the company’s LimiFlex Tension Band for patients suffering from degenerative spondylolisthesis with lumbar spinal

Empirical Spine Presents Data from Study of the LimiFlex™ — Empirical Spine Read More »

Sight Sciences to Report Third Quarter 2021 Financial Results on November 10, 2021

MENLO PARK, Calif., Oct. 27, 2021 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT) today announced it will report financial results for the quarter ended September 30, 2021 after the market close on Wednesday, November 10, 2021. The company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time /

Sight Sciences to Report Third Quarter 2021 Financial Results on November 10, 2021 Read More »

Mindera Health™ announces first patient enrolled in the MATCH Study; a clinical utility evaluation of the impact of Mind.Px™ on response rates of psoriasis patients who are prescribed biologics

Mind.Px brings personalized medicine to psoriasis patients by improving pre-treatment biologic drug class choice with >90% positive predictive value SAN DIEGO – October 21, 2021 – Mindera Health, developers of the ground-breaking Dermal Intelligence™ platform that is the first realization of personalized medicine in psoriasis, announced the enrollment of the first patient in the MATCH

Mindera Health™ announces first patient enrolled in the MATCH Study; a clinical utility evaluation of the impact of Mind.Px™ on response rates of psoriasis patients who are prescribed biologics Read More »

Homegrown medtech company Centese develops game-changing device for surgery patients –

A new Omaha-based medtech company has developed a self-cleaning chest tube system that provides more precise measurements for monitoring patients recovering from surgery on their heart or lungs.  Startup Centese developed the device, called Thoraguard. Through a novel self-irrigating mechanism, Thoraguard eliminates one of the main hazards of analog chest tubes: the need for medical…

Homegrown medtech company Centese develops game-changing device for surgery patients – Read More »

Potrero Medical Names Steve Okland as Chief Commercial Officer

HAYWARD, Calif., October 13, 2021 – Potrero Medical, innovator of the Accuryn Monitoring System, a sensory integrated foley catheter that provides real-time, actionable information to health care providers so they can take steps to prevent the progression of critical conditions such as acute kidney injury (AKI), announced that Steve Okland will join Potrero Medical as

Potrero Medical Names Steve Okland as Chief Commercial Officer Read More »